Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
At early stages of human life, the body is healthy and resilient and thus, is more adept at restoring lost cells. As the body ages, its ability to heal and restore such cells decreases, leading to cell death, in turn leading to aging. Moreover, early aging is caused by unhealthy lifestyle such as smoking and excessive consumption of packaged foods and alcohol. Signs of aging include increasing appearance of dark spots on the skin, sagging skin, lines & wrinkles, dullness, and patchy skin. Anti-aging treatment such as botulinum toxin therapy, chemical peels, microdermabrasion and usage of ant—wrinkle and anti-aging products aid in slowing the process of aging.
The global anti- aging treatment market is estimated to be valued at US$ 21.06 billion in 2020 and is expected to exhibit a CAGR of 7.3% over the forecast period (2020-2027).
Figure 1. Global Anti-aging Treatment Market Share (%) in Terms of Value, By Region, 2019
Increasing adoption of aesthetic procedures as an anti-aging treatment is expected to propel the market growth over the forecast period
The increasing number of people opting for aesthetic procedures such as microdermabrasion, chemical peel, and others for anti- aging treatment is expected to propel growth of the anti-aging treatment market over the forecast period. According to the International Society of Aesthetic Plastic Surgery around 2,051,984 facial rejuvenation procedures were performed worldwide in 2017, which included around 357,753 chemical peel and 268,423 microdermabrasion procedures.
Anti-aging Treatment Market Report Coverage
| Report Coverage |
Details |
| Base Year: |
2019 |
Market Size in 2019: |
US$ 19.63 Bn |
| Historical Data for: |
2016 to 2019 |
Forecast Period: |
2020 to 2027 |
| Forecast Period 2020 to 2027 CAGR: |
7.3% |
2027 Value Projection: |
US$ 34.49 Bn |
| Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
|
| Segments covered: |
- By Product Type: UV Absorbers, Anti-Wrinkle Products, Anti-Stretch Mark Products, Natural Products, Others.
- By Technology: Botulinum Toxin Therapy, Dermabrasion, Microdermabrasion, Chemical Peels, Fractional Laser Skin Resurfacing, Dermal Fillers, Nonablative Skin Rejuvenation.
- By End User: Hospitals, Skin Care Clinics, Homecare Settings, Others.
|
| Companies covered: |
Allergan Plc, Estée Lauder Companies, Shiseido Company, Beiersdorf AG, L'Oréal S.A, NuFACE, Ostium Cosmetics, PhotoMedex, Inc, Alma Laser, and Rodan & Fields, LLC
|
| Growth Drivers: |
- Increasing product approvals and launches
- Increasing number of aesthetic procedures
- Increasing collaborations, acquisitions, and partnerships
|
| Restraints & Challenges: |
- High cost of aesthetic procedures
|
Figure 2. Global Anti-aging Treatment Market Share (%), by Product Type, 2020
Increasing launch of new and advanced anti-aging products is expected to drive the market growth over the forecast period
Market players are focusing on enhancing their product portfolio by launching new and advanced anti-aging treatment devices, which is expected to drive the market growth over the forecast period. For instance, in January 2019, NuFACE, a provider of the microcurrent treatments in homecare settings, launched FIX line smoothing Serum and the FIX Line Smoothing Device. The device coupled with serum, targets the fine lines and wrinkles around the lips, eyes, and forehead.
Global Anti-Aging Treatment Market – Impact of Coronavirus (Covid-19) Pandemic
The American Society of Plastic Surgeons has recommended to postpone all the elective or non-essential services due to which the number of aesthetic procedures such as chemical peel, botulinum toxin therapy, dermabrasion, and others have decreased hindering the anti-aging treatment market growth. According to the article published in the Aesthetic Journal on April 03, 2020, around 81% of clinics are closed and 67% are experiencing reduction in revenue due to the COVID-19 lockdown in London.
Furthermore, several skincare and cosmetic companies are observing a decline in sales due to the COVID-19 pandemic. For instance, on May 12, 2020, Shiseido Company, a Japanese multinational personal care company, released its financial statement for the first quarter of 2020 reporting a 14.6% and 19.2% year-on-year net sales decline in the American and Asia Pacific business, respectively.
Anti-aging Treatment Market Restraint
High cost of aesthetic procedures is expected to hinder the market growth over the forecast period. According to the American Society of Plastic Surgeons, the average cost of botox treatment is US$ 397 in the U.S. while a single session of microdermabrasion costs around US$ 131 and the cost of chemical peel is around US$ 669.
Key Players
Major players operating in the global anti-aging treatment market include Allergan Plc, Estée Lauder Companies, Shiseido Company, Beiersdorf AG, L'Oréal S.A, NuFACE, Ostium Cosmetics, PhotoMedex, Inc, Alma Laser, Rodan & Fields, LLC, and others.
US :
INDIA :
UK :
JAPAN :
U.S. :
+1-206-701-6702
UK :
+44-020-8133-4027
JAPAN :
+81-50-5539-1737
INDIA :
+91-848-285-0837
Sales Office (U.S.) : 
